deltatrials
Completed PHASE1 NCT00361348

Palifermin DDI (Drug Drug Interaction)

An Open-label, Randomized, 2-part, Parallel Design Study to Characterize the Effect of Heparin on Palifermin Pharmacokinetics and the Effect of Palifermin on Heparin Pharmacodynamics in Healthy Subjects

Sponsor: Swedish Orphan Biovitrum

Conditions Healthy Volunteers
Interventions Heparin Palifermin
Updated 6 times since 2017 Last updated: Nov 5, 2014 Started: Dec 31, 2005 Primary completion: Jul 31, 2006 Completion: Jul 31, 2006

A PHASE1 clinical study on Healthy Volunteers, this trial is completed. The trial is conducted by Swedish Orphan Biovitrum and has accumulated 6 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE1

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1

    First recorded

Dec 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Swedish Orphan Biovitrum
Data source: Swedish Orphan Biovitrum

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.